Established gut health brand introduces stimulant-free metabolic support supplement featuring Berberine, 5-HTP, Saffron Extract, Chromium Picolinate, and Bupleurum Root
Established gut health brand introduces stimulant-free metabolic support supplement featuring Berberine, 5-HTP, Saffron Extract, Chromium Picolinate, and Bupleurum Root
BOISE, ID – September 2, 2026 – Gut Health UAB, the company behind the established ColonBroom brand of dietary supplements, today announced the commercial launch of ColonBroom GLP-1 Booster, a plant-based metabolic wellness capsule designed to support appetite signaling, blood sugar balance, and metabolic function. The product is now available to consumers through the company’s official website and authorized retail partners, including Amazon and GNC, and represents ColonBroom’s strategic expansion from its established gut health product line into the broader metabolic wellness category.
ColonBroom built its consumer reputation in the gut health and digestive wellness segment, where its original psyllium husk-based fiber supplement established a broad user base focused on digestive regularity and gastrointestinal comfort. The launch of ColonBroom GLP-1 Booster marks the brand’s first entry into the metabolic support category, responding to growing consumer interest in plant-based, non-stimulant approaches to appetite management and metabolic wellness. The product’s formulation draws on peer-reviewed research across five key ingredients, each selected for its documented presence in published nutritional and clinical science literature.
ColonBroom GLP-1 Booster is formulated as a capsule supplement containing five active ingredients: Berberine, Chromium Picolinate, 5-Hydroxytryptophan (5-HTP), Saffron Extract, and Bupleurum Root Extract. The formula is plant-based, vegan-friendly, non-GMO, gluten-free, and stimulant-free. It is packaged in a 60-capsule bottle designed as a 30-day supply at the recommended dosage of two capsules daily. The product does not contain pharmaceutical GLP-1 receptor agonists or synthetic hormones of any kind. Its formulation strategy centers on plant-derived ingredients that have been examined in peer-reviewed research for their potential roles in appetite, satiety, and metabolic function.
The formula’s lead ingredient, Berberine, is a plant alkaloid derived from herbs including goldenseal, Oregon grape, and barberry, with a documented history of use in traditional medicine systems and a growing body of modern clinical research. Research published in Nutrition & Diabetes examined berberineadministration and its relationship to GLP-1 secretion in animal models, finding that berberine protected intestinal cells associated with this signaling pathway. A review published in the Archives of Physiology and Biochemistry examined potential mechanisms of berberine in glucose metabolism, including pathways associated with appetite signaling and metabolic regulation. Educational materials published by UCLA Health have noted that berberine operates through mechanisms distinct from pharmaceutical interventions, and that its effects in published research reflect modest metabolic support as part of a broader wellness approach.
For more information, ingredient references, or product details, visit: colonbroom.com
Chromium Picolinate, a highly bioavailable form of the essential trace mineral chromium, has been the subject of clinical investigation for its role in carbohydrate metabolism and appetite regulation. Research published in the Journal of Psychosomatic Research examined chromium picolinate supplementation at doses of 600 to 1,000 micrograms daily and its associations with appetite-related outcomes, identifying differences in snacking and craving behaviors between supplemented and placebo groups over an eight-week period. The National Institutes of Health Office of Dietary Supplements has published educational materials on chromium, noting that research findings on its metabolic effects have been mixed across populations and that its relevance may be most pronounced in individuals with specific carbohydrate metabolism patterns. The inclusion of Chromium Picolinate in the ColonBroom GLP-1 Booster formula reflects this body of research and its documented relationship to blood sugar stability and carbohydrate-specific appetite patterns.
5-Hydroxytryptophan, commonly referred to as 5-HTP, is a naturally occurring amino acid that serves as a precursor to serotonin, the neurotransmitter involved in mood regulation, sleep architecture, and satiety signaling. A study published in the American Journal of Clinical Nutrition examined 5-HTP supplementation at 900 milligrams daily in a study population without dietary restrictions and observed differences in body weight and early satiety compared to placebo over a 12-week period, with researchers noting a reduction in carbohydrate intake in the supplemented group. A double-blind crossover study examining 5-HTP supplementation at approximately 656 milligrams daily over five weeks found differences in appetite and food intake in the supplemented group relative to placebo. Educational materials published by Memorial Sloan Kettering Cancer Center have noted that preliminary findings suggest 5-HTP may influence food intake and satiety, while emphasizing that further research is needed to establish consistent clinical outcomes across populations. The company notes that individuals taking serotonin-affecting medications, including SSRIs and MAOIs, should consult a qualified healthcare provider before use.
Saffron Extract, derived from the Crocus sativus plant, represents one of the more distinctively researched ingredients in the ColonBroom GLP-1 Booster formula, with published clinical investigation focused specifically on stress-related eating and snacking behavior. A randomized, placebo-controlled, double-blind study published in Nutrition Research examined a patented saffron extract in 60 mildly overweight women over an eight-week intervention period. The saffron group demonstrated statistically significant differences in body weight compared to placebo, reduced snacking frequency, and improved subjective satiety scores. The researchers concluded that saffron’s observed effects appeared to operate through mood-related mechanisms, with reductions in emotional and stress-driven eating contributing to the differences observed between groups. The inclusion of Saffron Extract in the ColonBroom GLP-1 Booster formula addresses the psychological and behavioral dimensions of appetite management — a component that single-pathway formulations frequently overlook.
Bupleurum Root Extract, derived from a plant with a long history in traditional Chinese medicine, rounds out the ColonBroom GLP-1 Booster formula as a botanical ingredient examined for its adaptogenic, anti-inflammatory, and digestive support properties. Bupleurum contains bioactive compounds called saikosaponins, which have been studied in published literature for their roles in liver function, stress response modulation, and systemic inflammation. Its inclusion in the formula reflects ColonBroom’s heritage in the digestive wellness space and the brand’s formulation philosophy of supporting metabolic wellness through multiple biological pathways simultaneously, rather than relying on a single active compound. As with all dietary supplements, the individual and combined effects of the ColonBroom GLP-1 Booster formula’s ingredients have not been evaluated by the Food and Drug Administration as a finished product.
The formulation strategy underlying ColonBroom GLP-1 Booster reflects a multi-pathway approach to metabolic wellness — a design principle in which each ingredient addresses a distinct biological or behavioral dimension of appetite and satiety rather than targeting a single mechanism. Berberine addresses metabolic signaling pathways examined in published research on blood sugar and appetite regulation. Chromium Picolinate targets carbohydrate metabolism and blood sugar stability. 5-HTP works through serotonin precursor activity to influence satiety signaling and mood balance, while Saffron Extract addresses stress-related and emotional dimensions of eating behavior. Bupleurum Root provides digestive and adaptogenic support consistent with ColonBroom’s established focus on gastrointestinal wellness. The theory underlying multi-pathway formulation is that by addressing appetite from multiple simultaneous angles — metabolic, neurochemical, behavioral, and digestive — the combined formulation may offer more comprehensive support than single-ingredient products. The company acknowledges that the specific combination of ingredients in ColonBroom GLP-1 Booster has not been evaluated as a complete formula in clinical trials, and that individual ingredient research does not guarantee equivalent outcomes for the finished product.
“ColonBroom has spent years building consumer trust in the gut health and digestive wellness space,” said a spokesperson for Gut Health UAB. “The launch of ColonBroom GLP-1 Booster represents a natural extension of that commitment — bringing the same ingredient transparency and research-informed formulation philosophy into the metabolic wellness category, where consumer demand for credible, plant-based options continues to grow.”
The global metabolic wellness supplement market has expanded significantly in recent years, driven in part by growing consumer awareness of lifestyle factors — including nutrition, sleep, stress, and physical activity — as determinants of long-term metabolic health. Within this landscape, consumer demand has increasingly favored products that are stimulant-free, ingredient-transparent, and supported by published scientific references rather than proprietary blends with undisclosed dosing. ColonBroom GLP-1 Booster is positioned within this segment as a plant-based, non-stimulant option designed for daily integration alongside healthy lifestyle practices. The company emphasizes that the product is designed to complement, not replace, foundational wellness behaviors, and that it is not a pharmaceutical product or a substitute for prescription medications of any kind.
ColonBroom GLP-1 Booster is manufactured and marketed in compliance with applicable regulations governing dietary supplements in the United States. The product’s statements have not been evaluated by the Food and Drug Administration, and it is not intended to diagnose, treat, cure, or prevent any disease. Gut Health UAB recommends that individuals with pre-existing health conditions, those taking prescription medications — particularly those affecting blood sugar, blood pressure, or serotonin levels — and women who are pregnant or nursing consult a qualified healthcare provider before beginning use. The company further notes that individual results may vary and that consistent daily use over a minimum of four to eight weeks is recommended before evaluating personal outcomes. The product is formulated for adults only.
“We built this formula on the same principles that have guided the ColonBroom brand from the beginning — transparency about what’s in the product, clarity about what the research actually shows, and honest positioning about what a dietary supplement can and cannot do,” the spokesperson added. “Consumers navigating the metabolic wellness category deserve that standard, and ColonBroom GLP-1 Booster was developed to deliver it.”
ColonBroom GLP-1 Booster is currently available through the official ColonBroom website as well as authorized retail partners including Amazon and GNC. The company offers a satisfaction guarantee on qualifying purchases; consumers are advised to verify the specific terms and conditions on the official website prior to ordering. Customer support is available directly through Gut Health UAB via the official contact channels listed on the company’s website. Gut Health UAB has indicated plans to continue expanding the ColonBroom product portfolio in the gut health and metabolic wellness categories over the coming fiscal year, building on the brand’s established consumer base and its reputation for ingredient transparency. For media representatives, healthcare professionals, and consumers seeking additional product information, scientific reference details, or ordering information, further details are available through the official ColonBroom website.
About ColonBroom / Gut Health UAB
Gut Health UAB is the company behind the ColonBroom brand of dietary supplements, headquartered in Vilnius, Lithuania. Founded on a commitment to gut health and digestive wellness, ColonBroom has built a broad consumer following through its flagship psyllium husk-based fiber supplement and has expanded its product line to include targeted metabolic wellness formulations. The company’s mission is rooted in transparency and consumer education — ensuring that every product in its portfolio is accompanied by clear ingredient disclosures, accessible explanations of the underlying research, and honest positioning about the role of dietary supplements within a broader healthy lifestyle. Gut Health UAB believes that informed consumers make better wellness decisions, and that responsibility to educate is inseparable from the responsibility to formulate. ColonBroom GLP-1 Booster is the brand’s flagship entry into the metabolic support category, available through the company’s direct-to-consumer website and authorized retail partners. For more information, visit colonbroom.com.
###
Media Contact:
Harold Ford, Head of Research, ColonBroom / Gut Health UAB
+1 (203) 872-9584
Aludarių street 3, Vilnius, Lithuania
For more press release distribution and guest post services, visit TS Newswire.
